Top compounds associated with response to MYO19


Feature Type Standardized
Nominal ANOVA
mRNA GW-405833 CTRPv2 pan-cancer AAC 0.057 0.1
mRNA CCT036477 CTRPv2 pan-cancer AAC -0.055 0.1
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.056 0.1
mRNA CCT007093 GDSC1000 pan-cancer AAC -0.054 0.1
mRNA Elesclomol GDSC1000 pan-cancer AAC 0.054 0.1
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.057 0.1
mRNA BRD-M00053801 CTRPv2 pan-cancer AAC -0.079 0.1
mRNA Pazopanib FIMM pan-cancer AAC 0.29 0.1
mRNA thalidomide CTRPv2 pan-cancer AAC -0.088 0.1
mRNA SN-38 CTRPv2 pan-cancer AAC 0.059 0.1
Download CSV